Daniel C. Lee, Ph.D., obtained his doctoral degree in pharmaceutical sciences, specializing in neuropharmacology and toxicology, in the research area of Parkinson’s disease and oxidative stress, from Florida A&M University’s College of Pharmacy and Pharmaceutical Sciences. Following this, he completed postdoctoral training at the University of South Florida's Morsani College of Medicine and Byrd Alzheimer's Center and Research Institute, where his research expanded to include Alzheimer's disease, aging, neuroinflammation, and proteinopathies. In 2010, he joined the USF Taneja College of Pharmacy as a founding faculty member and served as an assistant professor in the Department of Pharmaceutical Sciences. He was promoted to associate professor with tenure in 2017, and subsequently appointed as the Endowed Chair for William N. Sanders Chair in Geriatric Pharmacotherapy in 2018. Dr. Lee relocated to the University of Kentucky’s College of Medicine Sanders-Brown Center on Aging and became part of the University of Kentucky’s Alzheimer’s Disease Research Center as co-director of the Research Education Component. His laboratory studies various models of proteinopathies, including tauopathies, amyloid, synucleinopathies, and Alzheimer’s disease. Particularly, his work focuses on how aging impacts nutrient sensing/nutrient sensors dysfunction, longevity, and the interactions between L-arginine metabolism, polyamine metabolism through the lens of neuronal health. His lab also studies how post translational modifications impact tauopathies and proteinopathies.